Literature DB >> 8375435

Free radicals and their scavengers in Parkinson's disease.

T Yoshikawa1.   

Abstract

In recent years, it has been shown that active oxygen species or free radicals are closely involved in various diseases. Accumulating information supports the hypothesis that oxidative stress involving lipid peroxidation may contribute to the pathogenesis of Parkinson's disease. The objectives of this review are, first, to discuss some of the roles of active oxygen species in the pathogenesis of Parkinson's disease; second, to examine the possible effects of antioxidants as the protective therapy for Parkinson's disease, and, third, to summarize results from in vitro experiments that the dopamine agonist bromocriptine, used for treatment of Parkinson's disease, has a strong antioxidative effect.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375435     DOI: 10.1159/000118539

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  8 in total

1.  Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease.

Authors:  L Lih-Brody; S R Powell; K P Collier; G M Reddy; R Cerchia; E Kahn; G S Weissman; S Katz; R A Floyd; M J McKinley; S E Fisher; G E Mullin
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

Review 2.  Not Just from Ethanol. Tetrahydroisoquinolinic (TIQ) Derivatives: from Neurotoxicity to Neuroprotection.

Authors:  Alessandra T Peana; Valentina Bassareo; Elio Acquas
Journal:  Neurotox Res       Date:  2019-05-02       Impact factor: 3.911

3.  Antiperoxidative and antiinflammatory effect of Sida cordifolia Linn. on quinolinic acid induced neurotoxicity.

Authors:  S S Swathy; Seema Panicker; R S Nithya; M M Anuja; S Rejitha; M Indira
Journal:  Neurochem Res       Date:  2010-05-25       Impact factor: 3.996

Review 4.  Central nervous system agents for ischemic stroke: neuroprotection mechanisms.

Authors:  Rachna S Pandya; Lijuan Mao; Hua Zhou; Shuanhu Zhou; Jiang Zeng; A John Popp; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2011-06-01

5.  Cognitive-enhancing effect of quercetin in a rat model of Parkinson's disease induced by 6-hydroxydopamine.

Authors:  Napatr Sriraksa; Jintanaporn Wattanathorn; Supaporn Muchimapura; Somsak Tiamkao; Kamoltip Brown; Kowit Chaisiwamongkol
Journal:  Evid Based Complement Alternat Med       Date:  2011-07-18       Impact factor: 2.629

6.  Real-time visualization of oxidative stress-mediated neurodegeneration of individual spinal motor neurons in vivo.

Authors:  Isabel Formella; Adam J Svahn; Rowan A W Radford; Emily K Don; Nicholas J Cole; Alison Hogan; Albert Lee; Roger S Chung; Marco Morsch
Journal:  Redox Biol       Date:  2018-08-23       Impact factor: 11.799

7.  Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.

Authors:  Bayani Uttara; Ajay V Singh; Paolo Zamboni; R T Mahajan
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

8.  Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease.

Authors:  Yasir Hasan Siddique; Wasi Khan; Ambreen Fatima; Smita Jyoti; Saba Khanam; Falaq Naz; Fahad Ali; Braj Raj Singh; Alim Hussain Naqvi
Journal:  Dis Model Mech       Date:  2015-11-05       Impact factor: 5.758

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.